Nutritional status: copper deficiency
Nutritional status: copper deficiency
Did you know that copper is an essential trace mineral present in all tissues? It works with iron to help the body form red blood cells. It also helps keep the blood vessels, nerves, immune system and bones healthy while also aiding in iron absorption. In rare situations, copper deficiency can occur and lead to anaemia and osteoporosis.
Symptoms of copper deficiency include:
- Fatigue & weakness as cells use copper to generate ATP, the body’s main source of energy. This means that copper deficiency could affect your energy levels.
- Frequent sickness as copper plays an important role in maintaining a healthy immune system.
- Weak and brittle bones as copper is involved in the processes that create cross-links inside your bones. These cross-links ensure bones are healthy and strong.
- Problems with memory and learning as copper plays an important role in brain function and development.
Sensitivity to cold as copper, along with minerals like zinc, help maintain optimal thyroid gland function. Low thyroid levels can make you feel colder more easily.
There are many foods that are high in copper. These include leafy greens, including turnip, greens, spinach, kale and mustard greens. Asparagus and summer squash are two other excellent sources of copper while legumes, whole grains, nuts and seeds are also good sources of the substance.
Randox Reagents, RX and QC are helping to diagnose copper deficiency at the earliest possible stage. The Randox copper assay is used to measure the levels of copper in the blood in order to determine copper toxicity. Combining this with the Randox zinc assay can aid in identifying the cause of liver damage in a patient, leading to correct treatment and recovery.
Find out more about how Randox is helping to diagnose nutritional status and deficiencies here: https://www.randox.com/nutritional-status/
The Issues Surrounding Drug Residues in the Global Food Market
The potential presence of drug residue contaminants in food products destined for human consumption is an increasingly popular topic of conversation in the industry but what are the main challenges facing the industry to tackle this potential issue?
Drug residue contaminants in food products is a discussion that involves the global community but each individual country or trade bloc has their own protocols and regulations relating to the control and monitoring of residues. The different legislations are designed to protect the general public as well as the food industry interests in their individual countries. Any business that wishes to sell their products within other countries or regions must meet their legislative requirements relating to drug residues. These differences in regulations have increased the need for increased dialogue on the issue as well as the implementation of effective monitoring systems.
The industry must deal with the potential of residues from antibiotics and growth promoting hormones entering the food chain. This will involve ensuring correct dosage per animal and also adhering to withdrawal periods set for their region. The second issue the industry faces is the stigma received from the misuse of these antibiotics and growth promoting hormones.
While there is a potential for misuse it should always be noted that a producer’s main concern should always be animal health, which leads to a quality end product. The use of antibiotics is to ensure the health of the animal and to reduce the potential knock on effect of untreated diseases which could create a downturn on yield. Growth promoting hormones are used to increase this yield also but should never be done so at the expense of a safe end product.
Residues from particular drugs in food produce can have serious implications for human health. As such many countries have set Maximum Residue Limits (MRLs) or tolerances for these residues in food. The Maximum Residue Limit is the maximum concentration of a residue that can be present in a product from an animal or animal by product intended for the food supply. These MRLs mean that it is required by law in the enforcing countries that any product in the food chain cannot contain residue levels that are harmful to human health above these limits.
There has been controversy over measures to tackle drug residues in foods as there are no internationally accepted standards for many drugs. Ractopamine in particular has caused trade disputes as it is permitted in food production in some countries like the US & Canada, but the European Union, China, Taiwan and over 100 other countries have banned its use.
The real challenge the food industry faces is ensuring their testing methods are effective and reliable to ensure the safety of a variety of end products. To name a few of these diverse products we can look at the dairy, meat, seafood, feed and honey markets.
Dairy Market
The dairy industry is under constant scrutiny and pressure to constantly produce high volumes of milk whilst maintaining a superior standard of quality in their dairy products. As part of the production process various contaminants are administered to cattle in an effort to systematically treat various infectious diseases and maintain a healthy herd. A direct consequence of this is the requirement of routine monitoring and testing within farms and dairy processors to ensure that the levels of contaminants in milk are within legal regulations not exceeding Maximum Residue Limits and that unauthorised substances are not found at any level in milk.
Testing can be conducted at several points during the production process. Firstly, farm level testing can be carried out to screen milk from cows that have been separated from the herd and undergone antibiotic treatment. Secondly, the dairy processor is required to conduct testing both onsite taking samples from tankers and retrospective testing as a method of internal surveillance to ensure the milk supplied from several farms is within global regulatory limits. Thirdly, retailers can test the processed milk end product to guarantee the milk is antibiotic free before it’s added to supermarket shelves for consumers.
Meat Market
Global meat production and consumption have increased rapidly in recent decades. Worldwide meat production has tripled over the last four decades and increased 20 percent in just the last 10 years. Meanwhile, industrial countries are consuming growing amounts of meat, nearly double the quantity in developing countries. Mass quantities of antibiotics are used on livestock to reduce the impact of disease, contributing to antibiotic resistance in animals and humans alike. Worldwide, 80 percent of all antibiotics sold in 2009 were used on livestock and poultry, compared to only 20 percent used for human illnesses.
Growth promoters, which are tested for under the NRCP, are hormonal and antibiotic substances that may be used in food producing animals for growth promotion in livestock animals thus increasing the production of muscle meat and the reduction of fat. The type of growth promoter used is dependent on the animal species and mode of rearing with steroid growth promoters used for beef cattle and antibiotic growth promoters, which are usually added to feedstuffs, such as the coccidiostats used in the poultry industry and chlortetracycline used in the porcine industry. The rapid speed of meat production calls for the need to test for drug residues frequently to prevent them from ending up in the food chain.
Seafood Market
The global aquaculture industry has grown steadily over the past five decades, increasing at an average rate of 3.2%. However, this growth has come at a cost, with the industry facing many new challenges. Farmed seafood is often treated with medicated feeds which contain antibiotics such as leucomalachite green and nitrofurans for example to prevent from disease spreading, they are also exposed to other harmful residues used to treat algae etc. within the ‘pens’ where they are kept.
The FAO (2012) reported that 38% of fish produced globally is exported, highlighting the imbalances in regional supply and the changing tastes of the global consumer. This increased level of exporting and importing shows the importance of drug residue screening within the global aquaculture industry. This increased level of exporting and importing shows the importance of drug residue screening within the global aquaculture industry.
Feed Market
The global animal feed processing market is estimated at US$21.61 billion in 2018 and is projected to reach US$ 26.62 Billion by 2023. The market is driven by factors such as the rising awareness of feed nutrition and health, technological advancements in the equipment industry and increase in the demand for feed around the world. Medicated feeds containing veterinary are often used to help prevent disease within livestock and there are MRLs for feed which has created the need for testing as high levels of residues can have an effect on livestock health and also transfer through to meat products for human consumption. With humidity levels rising in recent years there has been an influx in the level of mycotoxins found within feed and cereals. These toxins are fungal and can affect both livestock and human health for example mycotoxicoses which is a disease which can affect the respiratory system. The main cause of mycotoxins within stored grains are when the grain is damp or cracked and kept in insufficient storage conditions. These factors have made it necessary for feed and cereals to be tested for both drug residues and mycotoxins to ensure that they do not end up within the food chain.
Honey Market
The global honey market is growing at a rapid pace and the global consumption of honey is to reach 2.5 million tones by 2022. This growth is driven for consumers demand for natural and healthy alternatives to artificial sweeteners over cane sugar. There is also a growing awareness of the health and healing benefits of honey which is driving the demand for the use of honey for medicinal use, manuka honey sales continue to grow for its antibacterial and anti-inflammatory properties. The rapid rise in demand for honey outweighs the amount that can be produced in a natural form globally due to a decline in the number of bees. This has influenced the quality of honey being produced as some producers take to diluting natural honey with high-fructose corn syrups in order to supply the demand. There is a requirement for keepers to treat bee colonies with antibiotics to prevent CCD and other diseases such as varroa mites and there is a chance that these harmful drug residues can be transferred through to the end product ‘natural’ honey. The use of antibiotic drugs in apiculture is globally restricted and there are no MRLs set for antibiotics in honey as it a natural product and needs to be antibiotic free, this has cause the need for testing both for drug residues and the overall quality of the honey being produced.
Detection
Due to the requirement to use a variety of drug treatments in the food industry and also the potential economic benefits to be gained from the use of growth promoters, there will continue to be use in animal production. However, as analytical methods of detection become more sensitive, producers are given further options for testing.
The surveillance for the potential presence of these residues of veterinary substances is regulated by the EU Directive 86/469/EEC. This directive outlines the guidelines for sampling and testing within a residue monitoring programme.
The requirement to meet these standard and the MRLs and detection levels outlined in the legislation has created a need for analytical methods to become more sensitive to ensure correct analysis. On some occasions MRL’s have been lowered which require a technology sensitive enough to detect very low concentrations in a sample.
One such screening method that is commonly used is the Enzyme-linked immunosorbent assay (ELISA) methods, which work well for testing and providing accurate results.
Randox Food have developed another method of analysis using the Evidence Investigator which uses similar methodology to ELISA methods. The analyser uses biochip array technology (BAT) to perform simultaneous quantitative detection of multiple analytes from a single sample and can be used across multiple matrix types including the products produced by the industries mentioned. The core technology is the Randox biochip, this contains an array of discrete test regions containing immobilized antibodies specific to the drug residues under test.
These methods are rapid, reliable, and sensitive so are able to detect residues in very small concentrations. The Randox methods are developed in line with EU Directive 86/469/EEC and as such are an effective testing method for multiple areas of the food industry.
For further information please contact the Randox Food Diagnostics team by emailing: info@randoxfood.com
Importance of Drug and Alcohol Testing in Family Law cases
“Family Law defines the legal attributes of the status, for example, the mutual rights and obligations of the married couple and provides remedies for regulating the relationship of the parties. Family Law determines the status of a child and provides mechanisms for regulating the exercise of parental responsibility.” – James Munby
James Munby spoke on the social justice for children and families and outlined the aims of the family justice system. He concluded with the ultimate aim stressing that the system must be about ‘securing social justice for children and their families.’
In specific circumstances in family law cases testing for drugs and alcohol may be required by various professional bodies involved in child custody cases, care proceedings or child protection cases. In cases regarding divorce and children, a dispute may arise during the process of discussions involving the custody of children. In these cases drug and alcohol testing may be sought if there has been a substance abuse claim against a parent fighting for custody or visitation.
Family law drug and alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have a quality of life they deserve. In addition it is also important to enable parents the opportunity to get the help and support they need and begin rehabilitation treatment. Doing the right thing by the child is the main priority, and where possible parent and child relationships are sought to be maintained.
Randox Testing Services – Medical Review
The comprehensive medical review service from Randox Testing Services offers independent and expert examination of positive results under medical confidentiality. As a cause for concern, positive results are recognised as a serious trade issue in all areas of drug and alcohol testing be it employee testing, testing carried out for family law issues or forensic toxicology.
A medical review report provides a detailed analysis of results to determine if there is a legitimate medical reason for positive results. Performed by a Medical Review Officer (MRO) the assessment involves a donor’s medical background to determine if, for example, a donor is taking or has taken in the recent past any prescriptive medication that may have affected results.
Our medical review service ensures confidence in results by eradicating any wrongful conclusions being made while helping to protect the rights of the person being tested and the person requiring the testing.
Family Law solicitors involved in care proceedings must take seriously the consequences of a parent or guardian testing positively for drugs or alcohol. The wrongful conclusion of a positive test result could lead to child parent separation for those involved in a custody battle or child protection case and cause unnecessary stress and anguish. A medical review protects the rights of all involved and ensures trust in the legal sector is maintained by determining legitimate reasons for a positive result while eradicating false conclusions from being made.
Randox Testing Services – Expert Witness Report
An expert witness report is a document providing a detailed outline of the drug and alcohol testing procedure followed and an interpretation of the results found. It is used as objective evidence in court and provides a detailed explanation of whether or not substances tested for were detected as well as information regarding chain of custody compliance.
Family law solicitors or social services may require an expert witness report for use in care proceedings relating to a dispute over the custody of children, or an issue concerning child protection. An expert witness report ensures non-biased and factual evidence for use in family court and guarantees confidence in results by ensuring sample integrity has been maintained throughout the testing process. In addition strict chain of custody procedures guarantees donor confidentiality which is vital in family court care proceedings.
Contact us today at testingservices@randox.com or call 0 161 741 2760 to speak to one of our experts.
We Are Randox | Life in Australia with Tanya Galewski
Here at Randox, we’re a diverse bunch. We have more than 1400 employees of 44 nationalities, including 300 research scientists and engineers. Needless to say, the Randox family is a multicultural one!
We have four key manufacturing and R&D sites – in County Antrim, Northern Ireland; Dungloe, County Donegal, Ireland; Bangalore, India; and the Greater Washington DC area, in the U.S.
We also have additional sales and distribution offices spread over 145 different countries, ranging from France to Argentina, Italy to China, and Vietnam to Australia – the focus of this month’s We Are Randox feature.
To learn more about the country famous for Ayers Rock, the Great Barrier Reef, and so many more natural wonders and landmarks, we sat down with Technical Sales Specialist Tanya Galewski at this week’s Annual Randox Sales Conference.
Read on to hear find out what it’s like to live in Australia, her tips for visiting the country, and of course, her top 5 must-see destinations!
Life in Australia is pretty much as you would expect – super relaxed and wonderfully warm.
But in saying that, we’re such outdoorsy people. We’re always out eating and drinking, and there are national parks and beaches everywhere, which means that we end up spending a lot more time outside than inside, which I think makes for a great atmosphere.
We’re just real go-getters!
My top 5 Must-See Destinations in Australia would be:
- Bondi Beach
(I live there so I have to say Bondi Beach!) But it certainly is one of Australia’s most iconic and most beautiful beaches. It really emulates the laid-back atmosphere of Australia, has wonderful cafés along the boardwalk, some beautiful shops, and of course the sand is totally pristine. If you like to surf the waves are incredible and the water itself is stunning.
- McLaren Vale
This is a beautiful wine region in the south of Australia which overlooks the ocean. Again, I may be biased as it is near my home town, but the wine produced there is totally world-class. You can take part in wine tasting events, visit farmers’ markets and enjoy live cookery demonstrations. It’s the perfect foodie destination.
- Noosa National Park
This is a national park in Queensland. It has the most gorgeous coastal walk where you can see dolphins, experience beautiful views of headlands and dunes, and go surfing. If you’re interested in Australian wildlife it’s also home to a range of animals including parrots, koalas, and frogs.
- Uluru
Moving away from the coastland, the next spot on my Must-See list would be Uluru (formerly known as Ayers Rock). It’s in the centre of Australia and is the absolute epitome of the Australian outback. Not only is it a geologist’s dream, it’s also really spiritual and you can’t help but be in awe when you see this wonder of the world.
- Melbourne
There is so much to see and do in the city of Melbourne. You could spend all your time there just eating and drinking and you still wouldn’t be able to visit all the wonderful cafés and restaurants!
The culture in Australia is quite diverse because it’s a multi-cultural country, meaning that our cuisine is also quite diverse. One of the good things about that is because there are so many people who specialise in what they cook, the food is exceptionally good. It’s helped also by the fact that we have such amazing home-grown produce.
Overall I would say that Australia is the perfect place for you if you love getting outdoors in the fresh air, enjoy trying new food, and like having the opportunity to take on new adventures.
With such a wide range of culture, climate and terrain all in the one country, there really is something for everybody.
We’re delighted to have had the chance to chat to Tanya, to learn about life in Australia and find out more about the country which hosts one of our international offices.
For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.
For current vacancies in Randox Australia, visit careers.randox.com
The future of healthcare has arrived at The Goodwood Festival of Speed
You visit the doctor because you think there is a problem. The doctor suspects it may be an infection but she’s not sure. A blood sample is taken and sent to the laboratory where three to five tests are run on it. Your blood does not show a positive reading for any of the tests conducted. You still don’t know what’s wrong. Does this sound familiar?
Enter a pioneering piece of technology called the Biochip. This health testing platform, from global diagnostics company Randox, and on show at this year’s Goodwood Festival of Speed, can currently run 49 different tests simultaneously – making sure you get the right diagnosis as fast as possible.
Current and futuristic developments in this critical strand of medicine, involving detailed analysis of blood to identify both current and future health risks, are appearing as part of the festival’s Future Lab project. Those visiting Future Lab will learn how technology can be utilised to improve the speed and accuracy of health diagnoses across the world.
With further plans to expand and enhance the Biochip even further – with capabilities to run over 1024 tests on a single blood sample – this technology is set to revolutionise the future of healthcare.
Randox Founder and Managing Director, Dr Peter FitzGerald, commented;
“For years we’ve been working behind-the-scenes with hospitals and laboratory professionals and, until now, our contribution to improving healthcare would not have been evident to the general public. But we know now that it’s time for us to come out – our technologies have the potential to transform healthcare around the world, and that matters to everyone.
“More sensitive, comprehensive and accurate technologies hold the promise of much earlier and effective diagnosis, often before symptoms appear – greatly improving healthcare outcomes and reducing the burden on healthcare services. And these technologies are directly available to the individual through our consumer division Randox Health, not just through GPs or hospitals.
“It is also a fact that diagnostics have historically been undervalued – in healthcare systems around the world laboratory technologies account for around 2% of overall budgets, yet 70%-80% of all healthcare decisions affecting diagnosis or treatment involve a laboratory investigation.”
Sensing the potential to improve healthcare through diagnostic innovation, Randox has invested significantly in the development of Biochip Array Technology, allowing many tests to be run simultaneously.
Dr FitzGerald continued;
“It’s taken over £285 million to see the fruition of this, the gold standard in testing. Our 300-strong team of research scientists and engineers are committed to exploring the thousands of markers of health and illness within the body and to each year unveil pioneering and innovative new tests to add to the Randox portfolio. Thanks to an annual investment of around 16% of turnover in this research and development, we have more innovations in development than any other healthcare company in the world.”
One such innovation, the concept of which is due to be revealed at the Goodwood Future Lab for the first time, is the unrivalled 32×32 Biochip. This highly anticipated testing platform will remarkably be able to provide patients with 1024 key pieces of information about their current and future health. Combined with advanced algorithms, the effect will be truly revolutionary.
Dr FitzGerald added;
“The 32×32 Biochip is key to unlocking true personalised medicine. Ultimately it acts as a roadmap of your health by predicting the health conditions of which you are personally at risk in the future. By taking preventive action you will be empowered to live healthier for longer. It’s the world’s first technology of its kind, capable of extending your life.”
The Randox Health Mobile Clinic, in which the public can directly access Randox technologies in the form of the world’s most comprehensive health check, will be at the Goodwood Hotel on Tuesday 17th and Wednesday 18th July. Those wishing to book can call 0800 2545 130 or can find out more by visiting the Randox Health website or downloading the app.
For further information please contact Randox PR by email: randoxpr@randox.com or by phoning 07980 738 120
The link between your nutrition and your mental health
Our nutritional health affects almost every process in the human body.
And nutrition gives us energy. A body without food is like a car without fuel, and we certainly wouldn’t put bad fuel in our car. Just like a car, consistently putting bad fuel into our bodies can have a detrimental effect.
For example, if you are a vegetarian, you may not have enough iron in your diet, or if you exclude dairy from your diet, you may not have enough calcium. Such insufficiency is well known for causing various health problems such as anaemia and brittle bones.
But what you may not know is that a lack of particular vitamins or minerals in our diet may also negatively affect our mental health. And it’s not surprising when you learn that the brain and the gastrointestinal systems are so closely linked.
Have you ever had “butterflies in your stomach”? Or been in a “gut-wrenching” situation? These phrases are used for a reason.
Your gastrointestinal system is sensitive to emotion – so whether you feel angry, sad, anxious or excited, this emotion may appear as symptoms in your stomach. The brain can even trigger the release of stomach juices just by thinking about your next meal.
And the connection can work both ways, as the gut-brain relationship is bidirectional. A troubled digestive system can send signals of pain or discomfort to the brain, and can therefore be the cause of mental illbeing.
Low levels of B-12 and other B vitamins such as vitamin B-6 and folate in particular are linked to depression. And this is because they play a role in producing brain chemicals that affect mood and other brain functions.
It’s therefore important to monitor whether nutritionally you are getting enough of these vitamins in your diet, which may in fact by the source of your mental illbeing. Our scientists at Randox Health thoroughly analyse up to 350 of your body’s biological markers to reveal what’s happening in your body, and if it turns out that a gut imbalance is having an effect on your mental health, there’s something you can do about it.
Determining the appropriate treatment may be as simple as eating more eggs, milk, cheese, milk products, meat, fish, shellfish or poultry, which are known sources of Vitamin B12.
So take control of your health – find out if your stomach problems are contributing to your mental concerns.
Contact the Randox Health team today.
Tel: 0800 2545 130
Email:info@randoxhealthni.com
How Randox is helping to diagnose nutritional status
At Randox, we’re dedicated to improving health worldwide and are consistently trying to break our own innovative records. Throughout the month of July, we’ll be introducing you to how we’re helping to diagnose nutritional deficiencies and define individual nutritional status among patients.
Zinc
Randox Reagents
Randox Reagents have the highest quality reagents on the market and a test menu comprising of over 113 assays. Unique to Randox is the zinc assay which is important in the diagnosis of kidney and liver damage.
Our zinc assay can be used to measure the levels of zinc in a patient’s urine providing insight into the levels of zinc in the body. This, combined with our copper assay, can aid in identifying the cause of liver damage in a patient, leading to correct treatment and recovery.
The RX series
The RX series offers the most comprehensive testing profile for assessing nutritional status to identify any nutritional deficiencies or any other nutritional issues within an individual.
The RX series zinc test can identify a zinc deficiency in an individual which is often a result of a low dietary intake and can lead to many problems including impaired immune and cognitive functions, kidney disease and diabetes.
Randox Quality Control
World-leading diagnostics would be nothing without world-leading quality control materials to ensure consistency and accuracy across all results. The Randox Acusera Liquid Chemistry Premium Plus control is the most comprehensive chemistry control available.
Stay tuned over the course of the month as we highlight how we’re helping in the fight against nutrient deficiencies.
Randox Biosciences: dedicated to advancing scientific discovery
Randox Laboratories is an international clinical diagnostic solutions company with over 35 years’ experience in the industry. Randox is a global market leader, providing revolutionary products for laboratories worldwide and is dedicated to improving health.
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. Spanning four key divisions; Life Sciences, Pharma Sciences, Research and Molecular; Randox Biosciences offers complete tailored solutions for clinical and research use.
From initial cultivation of raw materials for assay development, through to providing companion diagnostics, custom and molecular based assays across a range of therapy areas; Randox Biosciences is a trusted partner supplying quality diagnostic solutions to the clinical, life science, pharmaceutical, research and biopharma industries. We specialise in supplying academic centres, genetics laboratories and the global biopharmaceutical industry with products tailored to their specific needs.
Randox Biosciences Research team encompasses a knowledgeable group of who are dedicated to assisting your research project to completion. Recently, the research team has expanded to include Business Development Executives in America to support academic centres of excellence achieve their potential while utilising our quality products. We are proud to welcome Rebecca Newburg who will be focusing her efforts on the US-Midwest market and Celestine Eshiet who will be working on the US -West Coast.
We cover five areas of research such as Sport and Exercise, Cardiovascular, Metabolic, Immunology and Oncology. These five areas include our Metabolic Syndrome Array 1 & 2, Cytokine Arrays and Cardiac Array including CK-MB, H-FABP, Myoglobin and Troponin.
If you work in an academic centre and are interested in our variety of arrays, analysers whether that be chemistry or immunoassay analysers, or our reagents or quality control please do not hesitate to contact us at info@randoxbiosciences.com.
Randox Biosciences exhibit diagnostic innovations at UK-China Oncology Congress
Leading diagnostics firm Randox Laboratories has this week sent a delegation of scientists from its Biosciences Division to take part in the UK Exhibition of Oncology Excellence, between 25th and 29th June in Beijing and Guangzhou, in China.
The centrepiece of the UK-China Oncology Congress, the exhibition has been carefully curated to follow the “Science to Patient Pathway” for new therapies – from research to clinical trials, regulatory approval, manufacturing and distribution.
The Randox Biosciences team, over the course of the Congress event, will join a range of cancer-related seminars, offering an opportunity to learn about and influence Chinese government policies and priorities, and explore the latest trends and hot topics in oncology.
Julie-Ann O’Hare, Sales and Marketing Director for Randox Biosciences, commented;
“At Randox Biosciences we are actively seeking opportunities to strengthen business ties between the UK and China, and of course to showcase our innovative diagnostic capabilities to what is one of our most important and growing markets.
“We continue to expand our business presence there thanks to the ongoing pipeline of novel tests being produced from our innovative research and development programmes and enhanced manufacturing capabilities, including new facilities at the Randox Science Park in Northern Ireland.”
Exhibiting to a diverse audience of universities, hospitals, and laboratories responsible for prevention, diagnosis, treatment and care in oncology, Randox Biosciences have joined the exhibition to showcase their innovative diagnostic tests for bladder cancer and early detection of renal toxicity – including Chronic Kidney Disease and Acute Kidney Injury.
Julie-Ann continued;
“We continue to offer an increasing range of innovative diagnostic biomarkers to the growing and dynamic biotechnology markets.
“The focus on the importance of scientific research in the patient pathway, in enabling cancer diagnoses as soon as possible, offers us the perfect platform to introduce to China our latest pioneering oncological tests, including our test for bladder cancer.
“This test can stratify patients with haemeaturia (blood in the urine), who are at high risk of bladder cancer – reducing the number of unnecessary cystoscopies carried out on patients identified as ‘low risk’, significantly reducing healthcare costs and improving the waiting times for haematuria patients.”
For further information about the UK-China Oncology Congress, please email info@randoxbiosciences.com
Evidence Investigator | Adaptable, Efficient & Comprehensive
The Evidence Investigator is a compact, semi-automated benchtop analyser that offers efficient and comprehensive testing across a range of applications including clinical diagnostics, molecular, research, toxicology and food diagnostics.
Renowned for its versatility, robustness and effective reporting methods, the Evidence Investigator has been used in a wide range of laboratory settings for over 15 years. This highly advanced yet simple to use analyser has only one moving part, giving the user peace of mind.
The Evidence Investigator contains a host of innovative on-board data analysis features ensuring manual processes are kept to a minimum.
By utilising the same multiplex technology as the other Evidence Series analysers, the Evidence Investigator can process up to 44 results from a single sample, with a maximum throughput of up to 2376 tests per hour. Offering efficiency without compromising on accuracy, the Evidence Investigator is the perfect fit for medium throughput laboratories seeking maximum use of bench space.
Accurate and Robust
Like all the Evidence Series analysers, what sets it apart is technology. The Evidence Investigator is extremely well equipped to provide reliable results, while simultaneously robust enough to withstand frequent, heavy use.
Results are generated using a Charge Coupled Device (CCD) camera, which quantifies chemiluminescent light. This light measures the degree of binding between the patient sample and specific biochip bound ligands, generating highly accurate and reliable results.
Consolidation
The Evidence Investigator is the world’s first platform allowing consolidation of immunoassay and molecular diagnostics. This is achieved through utilising protein and DNA based biochips. By giving the user the ability to consolidate tests, the Evidence Investigator improves laboratory efficiency and reduces costs.
Advanced Reporting
The Evidence Investigator image processing software translates light signal generated from chemiluminescent reactions into analyte concentration. This removes the need for any manual processing of data.
Previously unreported tests can also be retrieved, so they can be tested retrospectively. This saves time, labour costs and reduces any reagents wastage. All data is then analysed on-board, removing issues related to human error and result manipulation.
About the Randox Evidence Series
The Evidence Series is set to revolutionise diagnostic testing forever. Offering unrivalled capabilities across all analysers, we truly believe that the Evidence Series range of immunoassay analysers can meet your diagnostic testing capabilities.
For more information on the Evidence Investigator, or any of the Evidence Series analysers, visit https://www.randox.com/evidence-series/ or contact us evidenceseries@randox.com.
